Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/15/2023 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $56.10 | $561k | | 06/15/2023 |
01/04/2023 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 2.4k | $39.16 | $93.8k | | 01/04/2023 |
11/28/2022 | Sage Therapeutics, Inc. | SAGE | Other (acquisition) | Common Stock | 5 | $38.17 | $190.8 | See footnote | 11/28/2022 |
06/16/2022 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 9.9k | $31.36 | $311.9k | | 06/16/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 825 | $177.58 | $146.5k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Non-Qualified Stock Option (right to buy) | 15k | $11.33 | $170k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 175 | $178.60 | $31.3k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 642 | $173.06 | $111.1k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 90 | $174.33 | $15.7k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 526 | $176.51 | $92.8k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 253 | $166.04 | $42k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 4.9k | $168.95 | $836k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 4.9k | $169.71 | $826.8k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 1.2k | $171.16 | $211.4k | | 04/01/2022 |
04/01/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 1.4k | $172.10 | $246.8k | | 04/01/2022 |
02/16/2022 | Karuna Therapeutics, Inc. | KRTX | Grant | Option (right to buy) | 146.9k | $111.97 | $16.4M | | 02/16/2022 |
01/04/2022 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Options (Right to buy) | 1.6k | $42.21 | $69.1k | | 01/04/2022 |
11/09/2021 | Sage Therapeutics, Inc. | SAGE | Other (acquisition) | Common Stock | 1 | $43.36 | $43.4 | See footnote | 11/09/2021 |
08/18/2021 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 1.2k | $106.10 | $125.3k | See footnote (1) | 08/17/2021 |
08/17/2021 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 1.2k | $105.63 | $125k | See footnote (1) | 08/17/2021 |
07/15/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4k | $171.95 | $693.3k | | 07/15/2021 |
06/10/2021 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $76.09 | $760.9k | | 06/10/2021 |
06/03/2021 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 15k | $4.23 | $63.4k | | 06/03/2021 |
02/23/2021 | Karuna Therapeutics, Inc. | KRTX | Grant | Option (right to buy) | 161.8k | $131.64 | $21.3M | | 02/23/2021 |
12/18/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 15k | $9.30 | $139.5k | | 12/18/2020 |
12/18/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 15k | $140.00 | $2.1M | | 12/18/2020 |
07/01/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4.6k | $148.77 | $681.5k | | 07/01/2020 |
06/29/2020 | Karuna Therapeutics, Inc. | KRTX | Sale | Common Stock | 292.2k | $103.50 | $30.2M | See footnote (1) | 06/29/2020 |
06/29/2020 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 292.2k | $0.11 | $32.1k | See footnote (1) | 06/29/2020 |
06/09/2020 | Sage Therapeutics, Inc. | SAGE | Grant | Stock Option (Right to Buy) | 10k | $36.47 | $364.7k | | 06/09/2020 |
06/04/2020 | Voyager Therapeutics, Inc. | VYGR | Grant | Stock Option (Right to Buy) | 15k | $11.79 | $176.8k | | 06/04/2020 |
02/14/2020 | Karuna Therapeutics, Inc. | KRTX | Grant | Stock Option (Right to Buy) | 140k | $99.72 | $14M | | 02/14/2020 |
02/10/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 30k | $130.00 | $3.9M | | 02/10/2020 |
02/10/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Non-Qualified Stock Option (right to buy) | 30k | $14.67 | $440.1k | | 02/10/2020 |
07/01/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 9k | $72.01 | $648.1k | | 07/01/2019 |
|